Table 3 Changes in administrative regulatory policies for health insurance
Republic of Korea | Japan | Germany | United States of America |
|---|---|---|---|
• Advance reimbursement before utilization review • Suspension of reporting institutional changes (staff, facilities) • Exclusion from bundled payment on COVID-19-related medical services | • Exception of reimbursement reduction related to additional beds when the approved number of beds under the Medical Act is exceeded • Suspension of reporting institutional changes (staff, facilities) | • Exception for the review of COVID-19-related claims • Shortening reimbursement period | • Waiving utilization review during public health emergency period |